Proof of Usefulness Report

Convergent Genomics

Analysis completed on 3/24/2026

+193.56

Proof of Usefulness Score

Gaining Momentum

Convergent Genomics targets a critical utility in precision medicine with non-invasive cancer detection via liquid biopsy. However, this submission suffers from highly unreliable and exaggerated claims (e.g., 'most people have used my product', 'everyone'). Despite the strong underlying technical premise, the severe lack of verifiable traction and poor response quality trigger significant quality factor penalties.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+100

Audience Reach Impact+10

Technical Innovation+56.25

Evidence Of Traction+0

Market Timing Relevance+35

Functional Completeness+2.5

Subtotal+203.75

Usefulness Multiplierx0.95

Final Score+194

Project Details

Project URL

convergentgenomics.com

Description

Convergent Genomics is a precision medicine company that combines advances in genomics and machine learning to detect cancer early and non-invasively. Convergent is a leader in applying these technologies for use in liquid biopsy from urine. Using genomic data, our products further integrate clinical scenarios and scientific literature to richly contextualize a patient’s specific risk and enable unique data-driven decision-making. Our Mission: Transforming cancer care through clear and actionable insights.

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline